Lynx1 Capital Management Lp - Net Worth and Insider Trading

Lynx1 Capital Management Lp Net Worth

The estimated net worth of Lynx1 Capital Management Lp is at least $28 Million dollars as of 2024-11-06. Lynx1 Capital Management Lp is the 10% Owner of TScan Therapeutics Inc and owns about 5,224,600 shares of TScan Therapeutics Inc (TCRX) stock worth over $28 Million. Details can be seen in Lynx1 Capital Management Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lynx1 Capital Management Lp has not made any transactions after 2023-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lynx1 Capital Management Lp

To

Lynx1 Capital Management Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lynx1 Capital Management Lp owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .

Click here to see the complete history of Lynx1 Capital Management Lp’s form 4 insider trades.

Insider Ownership Summary of Lynx1 Capital Management Lp

Ticker Comapny Transaction Date Type of Owner
TCRX TScan Therapeutics Inc 2023-05-31 10 percent owner

Lynx1 Capital Management Lp Latest Holdings Summary

Lynx1 Capital Management Lp currently owns a total of 1 stock. Lynx1 Capital Management Lp owns 5,224,600 shares of TScan Therapeutics Inc (TCRX) as of May 31, 2023, with a value of $28 Million.

Latest Holdings of Lynx1 Capital Management Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRX TScan Therapeutics Inc 2023-05-31 5,224,600 5.29 27,638,134

Holding Weightings of Lynx1 Capital Management Lp


Lynx1 Capital Management Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Lynx1 Capital Management Lp has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TScan Therapeutics Inc is the sale of 25,400 shares on May 31, 2023, which brought Lynx1 Capital Management Lp around $64,008.

Insider Trading History of Lynx1 Capital Management Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lynx1 Capital Management Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lynx1 Capital Management Lp Ownership Network

Ownership Network List of Lynx1 Capital Management Lp

No Data

Ownership Network Relation of Lynx1 Capital Management Lp

Insider Network Chart

Lynx1 Capital Management Lp Owned Company Details

What does TScan Therapeutics Inc do?

Who are the key executives at TScan Therapeutics Inc?

Lynx1 Capital Management Lp is the 10 percent owner of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Legal Officer Zoran Zdraveski , Chief Accounting Officer Leiden Dworak , and 10 percent owner Weston Nichols .

TScan Therapeutics Inc (TCRX) Insider Trades Summary

Over the past 18 months, Lynx1 Capital Management Lp made 1 insider transaction in TScan Therapeutics Inc (TCRX) with a net sale of 25,400. Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 20,000 shares made by Barbara Klencke , a net purchase of 67,027 shares made by Timothy J Barberich , and a net sale of 164,686 shares made by Zoran Zdraveski .

In summary, during the past 3 months, insiders sold 164,686 shares of TScan Therapeutics Inc (TCRX) in total and bought 15,000 shares, with a net sale of 149,686 shares. During the past 18 months, 190,086 shares of TScan Therapeutics Inc (TCRX) were sold and 87,027 shares were bought by its insiders, resulting in a net sale of 103,059 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TScan Therapeutics Inc Insider Transactions

No Available Data

Lynx1 Capital Management Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Lynx1 Capital Management Lp. You might contact Lynx1 Capital Management Lp via mailing address: 151 Calle De San Francisco, Suite 200 Pmb 1237, San Juan Pr 00901-1607.